Preferred Label : Drug-Eluting stents;

MeSH definition : Stents that are covered with materials that are embedded with chemicals that are gradually released into the surrounding milieu.;

MeSH synonym : drug-eluting stent; stents, drug eluting; stent, drug-eluting; stents, drug-eluting; drug eluting stents; Drug Eluting Stent;

Related MeSH term : Drug-Coated stents; Drug Coated Stents; Drug-Coated Stent; Stent, Drug-Coated; Stents, Drug-Coated; Stents, Drug Coated; Drug Coated Stent;

Details


Main resources

You can consult :

Stents that are covered with materials that are embedded with chemicals that are gradually released into the surrounding milieu.

https://www.has-sante.fr/jcms/p_3587266/fr/zilver-ptx
2025
France
health technology assessment
pneumothorax
paclitaxel
Drug-Eluting stents
Endoprosthesis
paclitaxel

---
https://www.has-sante.fr/jcms/p_3588029/fr/promus-premier-btk-promus-premier-otw-btk-et-promus-premier-monorail-btk
2025
France
health technology assessment
Everolimus
Drug-Eluting stents
everolimus
Endoprosthesis

---
https://www.has-sante.fr/jcms/p_3593830/fr/eluvia
2025
France
health technology assessment
paclitaxel
Drug-Eluting stents
paclitaxel
Endoprosthesis

---
https://www.has-sante.fr/jcms/p_3518366/fr/coroflex-isar-neo
2024
France
health technology assessment
Active State
pharmacologist
Stent
NEO Gene
Stenting
Active Control
Joy
sirolimus
Pet is as Active as it Has Been
Active License
Coat
Pharmacology
Cover
Sirolimus
Drug-Eluting stents
Endoprosthesis
Coronary Artery Stent
pharmacology
Product Part

---
https://www.has-sante.fr/jcms/p_3417225/fr/nitides
2023
France
health technology assessment
Drug-Eluting stents
Endoprosthesis
sirolimus

---
https://www.has-sante.fr/jcms/p_3264253/fr/titan-optimax
2021
false
false
false
France
titanium
coronary artery disease
treatment outcome
Drug-Eluting stents
coronary artery disease
health technology assessment
Drug-Eluting stents

---
https://www.has-sante.fr/jcms/p_3193740/fr/orsiro
2020
false
false
false
France
health technology assessment
stents
Drug-Eluting stents

---
https://www.has-sante.fr/jcms/p_3169471/fr/xience-prime-btk
2020
France
health technology assessment
Drug-Eluting stents
stents

---
https://www.has-sante.fr/jcms/p_3193726/fr/orsiro-mission
2020
France
health technology assessment
Religious Missions
stents
Drug-Eluting stents

---
https://www.has-sante.fr/portail/jcms/c_2902390/fr/yukon-chrome-pc
2019
false
false
false
France
Drug-Eluting stents
coronary disease
treatment outcome
health technology assessment
sirolimus

---
https://www.has-sante.fr/portail/jcms/c_2902384/fr/elunir
2019
false
false
false
France
Drug-Eluting stents
coronary disease
treatment outcome
health technology assessment
ridaforolimus
sirolimus

---
https://www.has-sante.fr/portail/jcms/c_2963184/fr/coroflex-isar
2019
false
true
false
France
coronary disease
treatment outcome
health technology assessment
Drug-Eluting stents
sirolimus

---
https://www.has-sante.fr/portail/jcms/c_2963205/fr/coroflex-isar-neo
2019
false
true
false
false
France
coronary disease
coronary disease
treatment outcome
health technology assessment
sirolimus
Drug-Eluting stents

---
Paclitaxel-Coated Balloons (PCB) and Paclitaxel-Eluting Stents (PES) for the Treatment of Peripheral Arterial Disease (PAD) and the Potential Risk of Long-Term All-Cause Mortality
https://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2019/69848a-fra.php
2019
false
false
false
Canada
French
English
equipment and supplies note
Drug-Eluting stents
angioplasty, balloon
paclitaxel
peripheral arterial disease
coated materials, biocompatible
cause of death

---
https://www.ansm.sante.fr/actualites/recommandations-de-traitement-de-larteriopathie-obliterante-des-membres-inferieurs-aomi-a-laide-de-dispositifs-medicaux-au-paclitaxel
2019
false
false
false
France
meta-analysis as topic
mortality, excess
Drug-Eluting stents
angioplasty, balloon
angioplasty, balloon
cardiovascular diseases
continuity of patient care
coated materials, biocompatible
guideline
paclitaxel
Lower limb occlusive arterial disease
arterial occlusive diseases
lower extremity
mortality

---
https://www.has-sante.fr/portail/jcms/c_2968543/fr/orsiro
2019
false
false
false
France
coronary disease
treatment outcome
evaluation of the transparency committee
sirolimus
Drug-Eluting stents

---
https://www.has-sante.fr/jcms/p_3101057/fr/combo-plus-stent
2019
France
health technology assessment
extracellular matrix
templates, genetic
pharmacology
monoclonal antibody
Monoclonal antibodies
pharmacologist
stents
sirolimus
Drug-Eluting stents
antibodies, monoclonal
Monoclonal antibodies
antibodies, anti-idiotypic
antigens, CD34
stents

---
https://www.has-sante.fr/jcms/p_3115341/fr/zilver-ptx
2019
France
health technology assessment
paclitaxel
pneumothorax
Drug-Eluting stents
paclitaxel
stents
stents

---
https://www.has-sante.fr/jcms/p_3115332/fr/promus-premier-btk-promus-premier-over-the-wire-btk-et-promus-premier-monorail-btk
2019
France
health technology assessment
Everolimus
tea, nos
stents
tea
tetrahydrocortisone
Drug-Eluting stents
everolimus
stents

---
http://www.sudoc.fr/240885392
2019
France
dissertations, academic
generations
Safety
safety
family characteristics
Meta-Analysis
Drug-Eluting stents
review literature as topic
meta-analysis as topic
Literature
meta-analysis

---
https://www.has-sante.fr/portail/jcms/c_2820665/fr/xience-sierra
2018
false
false
false
France
French
health technology assessment
active
Drug-Eluting stents
released
stents
stents

---
https://www.has-sante.fr/portail/jcms/c_2896009/fr/yukon-choice-pc
2018
France
health technology assessment
sirolimus
yukon territory
Drug-Eluting stents
stents
pharmacology
pharmacologist
stents

---
http://www.has-sante.fr/portail/jcms/c_2754728/fr/coroflex-isar
2017
false
false
false
France
French
health technology assessment
stents
Drug-Eluting stents
released
active
stents

---
https://www.has-sante.fr/portail/jcms/c_2772238/fr/ultimaster
2017
false
false
false
France
French
health technology assessment
active
Drug-Eluting stents
released
stents
stents

---
http://www.has-sante.fr/portail/jcms/c_2752881/fr/magmaris
2017
false
false
false
France
French
health technology assessment
stents
Drug-Eluting stents
released
active
stents

---
http://www.has-sante.fr/portail/jcms/c_2590001/fr/absorb
http://www.has-sante.fr/portail/jcms/c_2590000/fr/absorb
2016
false
false
false
false
France
French
health technology assessment
immunosuppressive agents
Drug-Eluting stents
coronary artery disease
Everolimus

---
http://www.has-sante.fr/portail/jcms/c_2590004/fr/absorb-gt1
2016
false
false
false
false
France
French
Drug-Eluting stents
coronary disease
blood vessel prosthesis implantation
blood vessel prosthesis
Everolimus

---
http://www.pharmactuel.com/index.php/pharmactuel/article/view/1065/850
2016
false
false
false
false
Canada
French
drug administration schedule
critical appraisal or critical reading
Drug-Eluting stents
drug therapy, combination
multicenter studies as topic
thrombosis
aspirin
aspirin
Prasugrel Hydrochloride
purinergic P2Y receptor antagonists
purinergic P2Y receptor antagonists
thienopyridine
platelet aggregation inhibitors
Drug-eluting coronary stent placement
hemorrhage
Coronary stent thrombosis
thienopyridine
stroke
myocardial infarction
time
platelet aggregation inhibitors
pyridines
pyridines
Clopidogrel

---
http://www.has-sante.fr/portail/jcms/c_2657488/fr/synergy
2016
false
false
false
false
France
French
health technology assessment
Drug-Eluting stents
Everolimus
coronary disease

---
http://www.has-sante.fr/portail/jcms/c_2062589/fr/biomatrix-flex
http://www.has-sante.fr/portail/jcms/c_2062588/fr/biomatrix-flex
2015
false
false
false
false
France
French
Drug-Eluting stents
treatment outcome
coronary artery disease
blood vessel prosthesis
blood vessel prosthesis implantation
sirolimus
immunosuppressive agents
umirolimus
health technology assessment

---
http://www.has-sante.fr/portail/jcms/c_2062613/fr/biomatrix-neoflex
http://www.has-sante.fr/portail/jcms/c_2062612/fr/biomatrix-neoflex
2015
false
false
false
false
France
French
coronary artery disease
health technology assessment
sirolimus
immunosuppressive agents
Drug-Eluting stents
blood vessel prosthesis
blood vessel prosthesis implantation
umirolimus
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_2062616/fr/biomatrix
http://www.has-sante.fr/portail/jcms/c_2062615/fr/biomatrix
2015
false
false
false
false
France
French
Drug-Eluting stents
treatment outcome
coronary artery disease
health technology assessment
blood vessel prosthesis
blood vessel prosthesis implantation
umirolimus

---
http://www.has-sante.fr/portail/jcms/c_2062734/fr/promus-premier-btk-monorail
http://www.has-sante.fr/portail/jcms/c_2062733/fr/promus-premier-monorail-btk
2015
false
false
false
false
France
French
health technology assessment
Drug-Eluting stents
blood vessel prosthesis
blood vessel prosthesis implantation
immunosuppressive agents
arterial occlusive diseases
lower extremity
Everolimus

---
http://www.has-sante.fr/portail/jcms/c_2062737/fr/promus-premier-btk-over-the-wire
http://www.has-sante.fr/portail/jcms/c_2062736/fr/promus-premier-over-the-wire
2015
false
false
false
false
France
French
health technology assessment
Drug-Eluting stents
blood vessel prosthesis
blood vessel prosthesis implantation
arterial occlusive diseases
lower extremity
immunosuppressive agents
Everolimus

---
http://cedit.aphp.fr/stents-coronaires-entierement-resorbables/
2015
false
false
false
France
health technology assessment
Drug-Eluting stents
coronary disease
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_2034376/fr/yukon-choice-pc
http://www.has-sante.fr/portail/jcms/c_2034375/fr/yukon-choice-pc
2015
false
false
false
false
France
French
health technology assessment
Drug-Eluting stents
coronary artery disease
sirolimus
immunosuppressive agents
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_2034379/fr/orsiro
http://www.has-sante.fr/portail/jcms/c_2034378/fr/orsiro
2015
false
false
false
false
France
French
Drug-Eluting stents
sirolimus
health technology assessment
coronary artery disease
immunosuppressive agents
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_2026097/en/zilver-ptx
http://www.has-sante.fr/portail/jcms/c_2026096/en/zilver-ptx
2015
false
false
false
false
France
French
Drug-Eluting stents
lower extremity
Lower limb occlusive arterial disease
arterial occlusive diseases
paclitaxel
blood vessel prosthesis implantation
blood vessel prosthesis

---
http://www.has-sante.fr/portail/jcms/c_2018891/fr/ultimaster
http://www.has-sante.fr/portail/jcms/c_2018890/fr/ultimaster
2015
false
false
false
false
France
French
Drug-Eluting stents
sirolimus
immunosuppressive agents
health technology assessment
coronary artery disease
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_2021476/fr/synergy
2015
false
false
false
false
France
French
Drug-Eluting stents
coronary artery disease
immunosuppressive agents
health technology assessment
Everolimus
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_2013093/fr/resolute-integrity
http://www.has-sante.fr/portail/jcms/c_2013092/fr/resolute-integrity
2015
false
false
false
false
France
French
Drug-Eluting stents
blood vessel prosthesis implantation
blood vessel prosthesis
coronary artery disease
sirolimus
immunosuppressive agents
zotarolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_2013096/fr/endeavor-resolute
2015
false
false
false
false
France
French
zotarolimus
sirolimus
immunosuppressive agents
Drug-Eluting stents
blood vessel prosthesis implantation
blood vessel prosthesis
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_2013081/fr/xience-alpine
http://www.has-sante.fr/portail/jcms/c_2013080/fr/xience-alpine
2015
false
false
false
false
France
French
immunosuppressive agents
Drug-Eluting stents
health technology assessment
coronary artery disease
blood vessel prosthesis
blood vessel prosthesis implantation
Everolimus
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_2011109/fr/resolute-integrity
http://www.has-sante.fr/portail/jcms/c_2011108/fr/resolute-integrity
2015
false
false
false
false
France
French
Drug-Eluting stents
health technology assessment
coronary artery disease
blood vessel prosthesis implantation
blood vessel prosthesis
zotarolimus
sirolimus
immunosuppressive agents
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_2013087/fr/resolute-onyx
2015
false
false
false
false
France
French
health technology assessment
Drug-Eluting stents
coronary artery disease
blood vessel prosthesis implantation
blood vessel prosthesis
zotarolimus
sirolimus
immunosuppressive agents
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_2011473/fr/promus-premier
http://www.has-sante.fr/portail/jcms/c_2011472/fr/promus-premier
2015
false
false
false
false
France
French
health technology assessment
coronary artery disease
Drug-Eluting stents
blood vessel prosthesis
blood vessel prosthesis implantation
immunosuppressive agents
Everolimus
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_2011476/fr/promus-element-plus
http://www.has-sante.fr/portail/jcms/c_2011475/fr/promus-element-plus
2015
false
false
false
France
French
Drug-Eluting stents
immunosuppressive agents
health technology assessment
coronary artery disease
Everolimus
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_2012834/fr/nobori
http://www.has-sante.fr/portail/jcms/c_2012833/fr/nobori
2015
false
false
false
false
France
French
Drug-Eluting stents
umirolimus
sirolimus
coronary artery disease
blood vessel prosthesis implantation
blood vessel prosthesis
immunosuppressive agents
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_2003841/fr/xience-v
http://www.has-sante.fr/portail/jcms/c_2003840/fr/xience-v
2015
false
false
false
false
France
French
Drug-Eluting stents
blood vessel prosthesis implantation
coronary artery disease
blood vessel prosthesis
sirolimus
health technology assessment
ACTIVE CORONARY STENT
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1733330/fr/promus-element-plus
http://www.has-sante.fr/portail/jcms/c_1733329/fr/promus-element-plus
2014
false
France
French
Drug-Eluting stents
coronary artery disease
health technology assessment
ACTIVE CORONARY STENT
Everolimus
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1726953/fr/orsiro
http://www.has-sante.fr/portail/jcms/c_1726952/fr/orsiro
2014
France
French
Drug-Eluting stents
sirolimus
health technology assessment
coronary artery disease
anti-bacterial agents
ACTIVE CORONARY STENT
antibiotic therapy
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_2003864/fr/xience-xpedition
http://www.has-sante.fr/portail/jcms/c_2003863/fr/xience-xpedition
2014
false
false
false
false
France
French
coronary artery disease
sirolimus
Drug-Eluting stents
blood vessel prosthesis implantation
blood vessel prosthesis
health technology assessment
ACTIVE CORONARY STENT
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_2003867/fr/xience-prime
http://www.has-sante.fr/portail/jcms/c_2003866/fr/xience-prime
2014
false
false
false
false
France
French
Drug-Eluting stents
coronary artery disease
blood vessel prosthesis
blood vessel prosthesis implantation
health technology assessment
ACTIVE CORONARY STENT
Everolimus
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1770297/fr/ultimaster
http://www.has-sante.fr/portail/jcms/c_1770296/fr/ultimaster
2014
false
false
false
false
France
French
Drug-Eluting stents
coronary artery disease
health technology assessment
sirolimus
immunosuppressive agents
CORONARY STENT, OTHER
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1755993/fr/coroflex-isar
http://www.has-sante.fr/portail/jcms/c_1755992/fr/coroflex-isar
2014
false
false
false
France
French
health technology assessment
Drug-Eluting stents
sirolimus
blood vessel prosthesis implantation
blood vessel prosthesis
coronary artery disease
ACTIVE CORONARY STENT
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1752088/fr/cre8
http://www.has-sante.fr/portail/jcms/c_1752087/fr/cre8
2014
false
false
false
France
French
health technology assessment
Drug-Eluting stents
coronary artery disease
sirolimus
immunosuppressive agents
ACTIVE CORONARY STENT
treatment outcome

---
http://has-sante.fr/portail/jcms/c_1748776/fr/titan-optimax
http://has-sante.fr/portail/jcms/c_1748775/fr/titan-optimax
2014
false
false
false
France
French
Drug-Eluting stents
health technology assessment
titanium
coronary artery disease
CORONARY STENT, OTHER
treatment outcome

---
http://has-sante.fr/portail/jcms/c_1752091/fr/helistent-titan-2
http://has-sante.fr/portail/jcms/c_1752090/fr/helistent-titan-2
2014
false
false
false
France
French
Drug-Eluting stents
health technology assessment
titanium
coronary artery disease
CORONARY STENT, OTHER
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1733327/fr/promus-premier
http://www.has-sante.fr/portail/jcms/c_1733326/fr/promus-premier
2014
false
France
French
health technology assessment
Drug-Eluting stents
coronary artery disease
ACTIVE CORONARY STENT
Everolimus
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1752091/fr/helistent-titan-2
2014
false
false
false
France
French
Drug-Eluting stents
health technology assessment
titanium
coronary artery disease
CORONARY STENT, OTHER
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1748776/fr/titan-optimax
http://www.has-sante.fr/portail/jcms/c_1748775/fr/titan-optimax
2014
false
false
false
France
French
Drug-Eluting stents
titanium
coronary artery disease
health technology assessment
CORONARY STENT, OTHER
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1350943/gamme-xience-prime-endoprothese-coronaire-a-liberation-de-principe-actif
http://www.has-sante.fr/portail/jcms/c_1350941/xience-prime-18-decembre-2012-4260-avis
http://www.has-sante.fr/portail/jcms/c_1350942/xience-prime-18-decembre-2012-4364-avis
false
France
French
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1536376/fr/synergy
http://www.has-sante.fr/portail/jcms/c_1536384/fr/synergy
2013
false
France
French
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
coronary disease

---
http://www.has-sante.fr/portail/jcms/c_1545470/fr/nobori-systeme-d-endoprothese-coronaire
http://www.has-sante.fr/portail/jcms/c_1545469/fr/nobori-23-avril-2013-4396-avis
2013
France
French
CORONARY STENT, OTHER
Drug-Eluting stents
coronary artery disease
health technology assessment
sirolimus
umirolimus
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1598316/fr/promus-premier-systeme-de-stent-coronaire-a-elution-d-everolimus
http://www.has-sante.fr/portail/jcms/c_1598315/fr/promus-premier-14-mai-2013-4440-avis
2013
false
France
French
CORONARY STENT, OTHER
Everolimus
Drug-Eluting stents
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1622853/fr/resolute-integrity
http://www.has-sante.fr/portail/jcms/c_1622852/fr/resolute-integrity
2013
France
French
CORONARY STENT, OTHER
health technology assessment
Drug-Eluting stents
sirolimus
zotarolimus
coronary artery disease
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1622853/fr/resolute-integrity
http://www.has-sante.fr/portail/jcms/c_1622852/fr/resolute-integrity
2013
France
French
CORONARY STENT, OTHER
health technology assessment
coronary artery disease
Drug-Eluting stents
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1625028/fr/xience-prime-btk
http://www.has-sante.fr/portail/jcms/c_1625027/fr/xience-prime-btk
2013
false
France
French
PERIPHERAL STENT, OTHER
Everolimus
Drug-Eluting stents
health technology assessment
arterial occlusive diseases
lower extremity
immunosuppressive agents
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1647377/fr/gamme-xience-xpedition
http://www.has-sante.fr/portail/jcms/c_1647376/fr/gamme-xience-xpedition
2013
false
France
French
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1711197/fr/promus-element-plus-btk-monorail-btk
http://www.has-sante.fr/portail/jcms/c_1715145/fr/promus-element-plus-btk-monorail
2013
France
French
Drug-Eluting stents
health technology assessment
lower extremity
arterial occlusive diseases
PERIPHERAL STENT, OTHER
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1711208/fr/promus-element-plus-btk-over-the-wire
http://www.has-sante.fr/portail/jcms/c_1715141/fr/promus-element-plus-btk-over-the-wire
2013
France
French
Drug-Eluting stents
health technology assessment
lower extremity
arterial occlusive diseases
PERIPHERAL STENT, OTHER
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1716229/fr/xience-prime
http://www.has-sante.fr/portail/jcms/c_1716228/fr/xience-prime
2013
false
France
French
Drug-Eluting stents
health technology assessment
coronary artery disease
immunosuppressive agents
ACTIVE CORONARY STENT
Everolimus
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1716226/fr/xience-xpedition
http://www.has-sante.fr/portail/jcms/c_1716225/fr/xience-xpedition
2013
false
France
French
Drug-Eluting stents
coronary artery disease
health technology assessment
immunosuppressive agents
ACTIVE CORONARY STENT
Everolimus
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1716211/fr/xience-v
http://www.has-sante.fr/portail/jcms/c_1716210/fr/xience-v
2013
false
France
French
Drug-Eluting stents
immunosuppressive agents
coronary artery disease
health technology assessment
ACTIVE CORONARY STENT
Everolimus
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1715363/fr/biomatrix
http://www.has-sante.fr/portail/jcms/c_1716081/fr/biomatrix
2013
France
French
Drug-Eluting stents
coronary artery disease
health technology assessment
sirolimus
umirolimus
ACTIVE CORONARY STENT
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1715362/fr/biomatrix-flex
http://www.has-sante.fr/portail/jcms/c_1716084/fr/biomatrix-flex
2013
France
French
Drug-Eluting stents
coronary artery disease
sirolimus
umirolimus
health technology assessment
ACTIVE CORONARY STENT
treatment outcome

---
https://www.revmed.ch/RMS/2013/RMS-381/Stents-coronariens-bioresorbables-une-revolution
2013
Switzerland
French
Drug-Eluting stents
journal article
coronary restenosis
Drug-Eluting stents
coronary disease
coronary thrombosis
CORONARY STENT, OTHER

---
http://www.has-sante.fr/portail/jcms/c_868765/fiche-de-bon-usage-angioplastie-coronarienne-interet-et-limites-des-stents-actifs
https://www.has-sante.fr/jcms/r_1437970
2012
true
France
French
CORONARY STENT, OTHER
Drug-Eluting stents
blood vessel prosthesis
coronary disease
angioplasty, balloon, coronary
guidelines for medical devices use

---
http://www.has-sante.fr/portail/jcms/c_1350944/gamme-xience-v-endoprothese-coronaire-a-liberation-de-principe-actif
http://www.has-sante.fr/portail/jcms/c_1350947/xience-v-18-decembre-2012-4244-avis
http://www.has-sante.fr/portail/jcms/c_1350948/xience-v-18-decembre-2012-4263-avis
2012
false
France
French
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1350928/gamme-xience-xpedition-endoprothese-coronaire-a-liberation-de-principe-actif
http://www.has-sante.fr/portail/jcms/c_1351201/xience-xpedition-18-decembre-2012-4410-avis
http://www.has-sante.fr/portail/jcms/c_1351207/xience-xpedition-18-decembre-2012-4354-avis
2012
false
France
French
ACTIVE CORONARY STENT
Everolimus
coronary artery disease
Drug-Eluting stents
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1237054/cre8-15-mai-2012-4218-avis
http://www.has-sante.fr/portail/jcms/c_1250477/cre-8-15-mai-2012-4218-avis
2012
France
French
health technology assessment
ACTIVE CORONARY STENT
Drug-Eluting stents
sirolimus
coronary artery disease
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1216621/nobori-21-fevrier-2012-4217-avis
http://www.has-sante.fr/portail/jcms/c_1231920/nobori-21-fevrier-2012-4217-avis
2012
France
French
ACTIVE CORONARY STENT
coronary artery disease
Drug-Eluting stents
sirolimus
umirolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1351909/resolute-integrity
2012
France
French
CORONARY STENT, OTHER
coronary artery disease
Drug-Eluting stents
zotarolimus
sirolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1064064/promus-element-14-juin-2011-3836-avis
http://www.has-sante.fr/portail/jcms/c_1064065/promus-element-14-juin-2011-3836-avis
2011
false
France
French
ACTIVE CORONARY STENT
Everolimus
health technology assessment
Drug-Eluting stents
coronary artery disease
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1297487/taxus-element-29-novembre-2011-3996-synthese-d-avis
2011
France
French
ACTIVE CORONARY STENT
treatment outcome
coronary artery disease
paclitaxel
tubulin modulators
Drug-Eluting stents
health technology assessment
guidelines for medical devices use

---
http://www.has-sante.fr/portail/jcms/c_1237197/xience-v-3857-et-xience-prime-3869-27-septembre-2011-synthese-d-avis
http://www.has-sante.fr/portail/jcms/c_1255529/xience-v-3857-xience-prime-3859-27-septembre-2011-synthese-d-avis
2011
false
France
French
health technology assessment
guidelines for medical devices use
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
coronary artery disease
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1045967/promus-et-promus-element-12-octobre-2010-3009-synthese-d-avis
2011
false
France
French
ACTIVE CORONARY STENT
health technology assessment
guidelines for medical devices use
Everolimus
Drug-Eluting stents
coronary artery disease
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1197007/endeavor-resolute-3834-et-resolute-integrity-3835-12-juillet-2011-synthese-d-avis
http://www.has-sante.fr/portail/jcms/c_1216278/endeavor-resolute-3834-resolute-integrity-3835-12-juillet-2011-synthese-d-avis
2011
France
French
ACTIVE CORONARY STENT
sirolimus
Drug-Eluting stents
zotarolimus
sirolimus
coronary artery disease
health technology assessment
guidelines for medical devices use
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1122211/taxus-element-29-novembre-2011-3996-avis
http://www.has-sante.fr/portail/jcms/c_1146959/taxus-element-29-novembre-2011-3996-avis
2011
France
French
ACTIVE CORONARY STENT
Drug-Eluting stents
paclitaxel
coronary stenosis

---
http://www.has-sante.fr/portail/jcms/c_1068582/xience-prime-27-septembre-2011-3859-avis
http://www.has-sante.fr/portail/jcms/c_1100486/xience-prime-27-septembre-2011-3859-avis
2011
false
France
French
health technology assessment
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
coronary artery disease
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1068588/xience-v-27-septembre-2011-3857-avis
http://www.has-sante.fr/portail/jcms/c_1100488/xience-v-27-septembre-2011-3857-avis
2011
false
France
French
health technology assessment
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
coronary artery disease
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1092597/promus-element-plus-13-septembre-2011-3932-avis
http://www.has-sante.fr/portail/jcms/c_1098120/promus-element-plus-13-septembre-2011-3932-avis
2011
false
France
French
health technology assessment
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
coronary artery disease
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1068127/resolute-integrity-12-juillet-2011-3835-avis
http://www.has-sante.fr/portail/jcms/c_1079790/resolute-integrity-12-juillet-2011-3835-avis
2011
France
French
ACTIVE CORONARY STENT
coronary artery disease
Drug-Eluting stents
sirolimus
zotarolimus
sirolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1067927/endeavor-resolute-12-juillet-2011-3834-avis
http://www.has-sante.fr/portail/jcms/c_1079788/endeavor-resolute-12-juillet-2011-3834-avis
2011
France
French
ACTIVE CORONARY STENT
diagnostic uses of chemicals
Drug-Eluting stents
zotarolimus
sirolimus
coronary artery disease
sirolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1058487/promus-14-juin-2011-3832-avis
http://www.has-sante.fr/portail/jcms/c_1064062/promus-14-juin-2011-3832-avis
2011
false
France
French
ACTIVE CORONARY STENT
Everolimus
health technology assessment
Drug-Eluting stents
coronary artery disease
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1033010/xience-v-22-mars-2011-3398-avis
http://www.has-sante.fr/portail/jcms/c_1035155/xience-v-23-mars-2011-3398-avis
2011
false
France
French
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1033013/xience-prime-22-mars-2011-3399-avis
http://www.has-sante.fr/portail/jcms/c_1035150/xience-prime-23-mars-2011-3399-avis
2011
false
France
French
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1045974/xience-v-22-mars-2011-3398-synthese-d-avis
http://www.has-sante.fr/portail/jcms/c_1053203/xience-v-3398-xience-prime-3399-22-mars-2011-synthese-d-avis
2011
false
France
French
ACTIVE CORONARY STENT
health technology assessment
guidelines for medical devices use
Everolimus
Drug-Eluting stents
coronary artery disease
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1045976/xience-prime-22-mars-2011-3399-synthese-d-avis
2011
false
France
French
ACTIVE CORONARY STENT
guidelines for medical devices use
health technology assessment
Everolimus
Drug-Eluting stents
coronary artery disease
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_973405/xience-v-29-juin-2010-2533-avis
http://www.has-sante.fr/portail/jcms/c_973400/xience-v-29-juin-2010-2533-avis
2010
false
France
French
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_973407/xience-prime-29-juin-2010-2532-avis
http://www.has-sante.fr/portail/jcms/c_973409/xience-prime-29-juin-2010-2532-avis
2010
false
France
French
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_950926/endeavor-04-mai-2010-2373-avis
http://www.has-sante.fr/portail/jcms/c_950927/endeavor-04-mai-2010-2373-avis
2010
France
French
ACTIVE CORONARY STENT
Drug-Eluting stents
immunosuppressive agents
zotarolimus
sirolimus
coronary artery disease
sirolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_996539/zilver-ptx-09-novembre-2010-2807-avis
http://www.has-sante.fr/portail/jcms/c_1096190/zilver-09-novembre-2010-2807-avis
2010
France
French
PERIPHERAL STENT, OTHER
ACTIVE CORONARY STENT
health technology assessment
Drug-Eluting stents
lower extremity
paclitaxel
arterial occlusive diseases
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_950917/endeavor-sprint-rx-04-mai-2010-2377-avis
http://www.has-sante.fr/portail/jcms/c_950919/endeavor-sprint-04-mai-2010-2377-avis
2010
France
French
ACTIVE CORONARY STENT
Drug-Eluting stents
immunosuppressive agents
sirolimus
zotarolimus
coronary artery disease
sirolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_980895/taxus-element-14-septembre-2010-2721-avis
http://www.has-sante.fr/portail/jcms/c_984143/taxus-element-14-septembre-2010-2721-avis
2010
France
French
ACTIVE CORONARY STENT
Drug-Eluting stents
blood vessel prosthesis
coronary disease
paclitaxel

---
http://www.has-sante.fr/portail/jcms/c_1001613/endeavor-et-endeavor-sprint-rx-04-mai-2010-2373-2377-synthese-d-avis
http://www.has-sante.fr/portail/jcms/c_1016552/endeavor-endeavor-sprint-04-mai-2010-2373-2377-synthese-d-avis
2010
France
French
ACTIVE CORONARY STENT
Drug-Eluting stents
zotarolimus
sirolimus
sirolimus
health technology assessment
guidelines for medical devices use
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1001631/xience-v-et-xience-prime-29-juin-2010-2532-2533-synthese-d-avis
http://www.has-sante.fr/portail/jcms/c_1016556/xience-v-xience-prime-29-juin-2010-2532-2533-synthese-d-avis
2010
false
France
French
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
coronary artery disease
health technology assessment
guidelines for medical devices use
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1011979/resolute-integrity-21-decembre-2010-3352-avis
2010
France
French
ACTIVE CORONARY STENT
Drug-Eluting stents
coronary artery disease
zotarolimus
sirolimus
sirolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_994680/endeavor-resolute-12-octobre-2010-2806-avis
http://www.has-sante.fr/portail/jcms/c_994684/endeavor-resolute-12-octobre-2010-2806-avis
2010
France
French
ACTIVE CORONARY STENT
coronary artery disease
Drug-Eluting stents
zotarolimus
sirolimus
sirolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_991919/promus-12-octobre-2010-3009-avis
http://www.has-sante.fr/portail/jcms/c_991921/promus-12-octobre-2010-3009-avis
2010
false
France
French
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
blood vessel prosthesis
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_940810/promus-element-long-cnedimts-du-23-mars-2010-2504
http://www.has-sante.fr/portail/jcms/c_941548/promus-element-long-cnedimts-du-23-mars-2010-2504
2010
false
France
French
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
immunosuppressive agents
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_773453/taxus-liberte
http://www.has-sante.fr/portail/jcms/c_779546/cepp-1949-taxus-liberte
2009
France
French
ACTIVE CORONARY STENT
Drug-Eluting stents
blood vessel prosthesis
paclitaxel
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_892971/xience-prime-cnedimts-du-08-decembre-2009-2310
http://www.has-sante.fr/portail/jcms/c_892972/xience-prime-cnedimts-du-08-decembre-2009-2310
2009
false
France
French
ACTIVE CORONARY STENT
Everolimus
immunosuppressive agents
Drug-Eluting stents
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_892686/promus-element-cnedimts-du-08-decembre-2009-2311
http://www.has-sante.fr/portail/jcms/c_892968/promus-element-cnedimts-du-08-decembre-2009-2311
2009
false
France
French
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
immunosuppressive agents
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_867966/evaluation-des-endoprotheses-coronaires-a-liberation-de-principe-actif
http://www.has-sante.fr/portail/jcms/c_868702/evaluation-des-endoprotheses-coronaires-a-liberation-de-principe-actif
http://www.has-sante.fr/portail/jcms/c_868709/annexes-du-rapport-d-evaluation-des-endoprotheses-a-liberation-de-principe-actif
2009
true
France
French
ACTIVE CORONARY STENT
Contraindications, Procedure
Drug-Eluting stents
blood vessel prosthesis
coronary artery disease
insurance, health, reimbursement
angioplasty, balloon, coronary
hospitalization
reoperation
stents
treatment outcome
Cost-Benefit analysis
Drug-Eluting stents
Drug-Eluting stents
Drug-Eluting stents
health technology assessment
economic evaluation
comparative study

---
http://www.has-sante.fr/portail/jcms/c_864993/xience-prime-cnedimts-du-22-septembre-2009-2246
http://www.has-sante.fr/portail/jcms/c_864995/xience-prime-cnedimts-du-22-septembre-2009-2246
2009
false
France
French
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
blood vessel prosthesis
coronary artery disease
immunosuppressive agents
health technology assessment
treatment outcome

---
https://smf.swisshealthweb.ch/fr/article/doi/fms.2009.06910/
2009
false
Switzerland
French
CORONARY STENT, OTHER
Drug-Eluting stents
coronary restenosis
risk assessment
Drug-Eluting stents
journal article
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_938820/genous-bio-engineered-r-stent-endoprothese-1891-cnedimts-du-22-decembre-2009
http://www.has-sante.fr/portail/jcms/c_938834/genous-bio-engineered-r-stent-endoprothese-1891-cnedimts-du-22-decembre-2009
2009
France
French
CORONARY STENT, OTHER
Drug-Eluting stents
coronary artery disease
antigens, CD34
health technology assessment
guidelines for medical devices use
treatment outcome

---
http://www.cbip.be/Folia/Index.cfm?FoliaWelk=F36F07D
2009
Belgium
French
Dutch
CORONARY STENT, OTHER
Drug-Eluting stents
coronary restenosis
treatment outcome
risk factors
acute coronary syndrome
journal article

---
http://www.has-sante.fr/portail/display.jsp?id=c_643789
http://www.has-sante.fr/portail/display.jsp?id=c_643795
2008
France
French
ACTIVE CORONARY STENT
Drug-Eluting stents
paclitaxel
heart failure
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_659705
http://www.has-sante.fr/portail/display.jsp?id=c_659735
2008
France
French
ACTIVE CORONARY STENT
coronary artery disease
Drug-Eluting stents
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_725165/taxus-liberte
http://www.has-sante.fr/portail/jcms/c_725166/taxus-liberte-cepp-1858
2008
France
French
ACTIVE CORONARY STENT
Drug-Eluting stents
coronary artery disease
paclitaxel
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_731501/pro-kinetic-energy
http://www.has-sante.fr/portail/jcms/c_731503/pro-kinetic-energy-cepp-1930
2008
France
French
CORONARY STENT, OTHER
Drug-Eluting stents
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_731812/cypher-select-plus
http://www.has-sante.fr/portail/jcms/c_731821/cypher-select-plus-cepp-1865
2008
France
French
ACTIVE CORONARY STENT
Drug-Eluting stents
coronary artery disease
health technology assessment
treatment outcome

---
https://rmlg.uliege.be/article/1786
2008
Belgium
French
Drug-Eluting stents
risk assessment
cardiovascular diseases
journal article

---
http://www.has-sante.fr/portail/jcms/c_716885/endeavor
http://www.has-sante.fr/portail/jcms/c_716886/endeavor-cepp-1879
2008
France
French
ACTIVE CORONARY STENT
Drug-Eluting stents
sirolimus
coronary artery disease
zotarolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_703389/nobori
http://www.has-sante.fr/portail/jcms/c_703391/nobori-cepp-1784
2008
France
French
ACTIVE CORONARY STENT
Drug-Eluting stents
coronary artery disease
sirolimus
umirolimus
health technology assessment
treatment outcome

---
https://smf.swisshealthweb.ch/fr/article/doi/fms.2008.06378/
2008
false
Switzerland
French
Drug-Eluting stents
Drug-Eluting stents
journal article
image

---
http://www.has-sante.fr/portail/jcms/c_671429/endeavor
http://www.has-sante.fr/portail/jcms/c_671462/cepp-1744
2008
France
French
ACTIVE CORONARY STENT
Drug-Eluting stents
sirolimus
angioplasty, balloon, coronary
coronary restenosis
zotarolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_666117/cypher-select-plus
http://www.has-sante.fr/portail/jcms/c_670970/cepp-1783
2008
France
French
ACTIVE CORONARY STENT
coronary artery disease
sirolimus
Drug-Eluting stents
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_667032/helistent-titan-2
http://www.has-sante.fr/portail/jcms/c_670950/cepp-1633
2008
France
French
CORONARY STENT, OTHER
Drug-Eluting stents
coronary artery disease
titanium
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_666118/cypher-select
http://www.has-sante.fr/portail/jcms/c_670992/cepp-1747
2008
France
French
ACTIVE CORONARY STENT
sirolimus
Drug-Eluting stents
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_666117
http://www.has-sante.fr/portail/jcms/c_670970/cepp-1783
2008
France
French
ACTIVE CORONARY STENT
prostatic neoplasms
brachytherapy
Drug-Eluting stents
health technology assessment
treatment outcome

---
https://rmlg.uliege.be/article/1816
2008
Belgium
French
CORONARY STENT, OTHER
Drug-Eluting stents
diabetes mellitus
coronary artery disease
risk factors
risk assessment
diabetes complications
journal article

---
http://www.has-sante.fr/portail/display.jsp?id=c_658717
http://www.has-sante.fr/portail/display.jsp?id=c_658721
2008
false
France
French
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_658716
http://www.has-sante.fr/portail/display.jsp?id=c_658718
2008
France
French
ACTIVE CORONARY STENT
coronary artery disease
sirolimus
Drug-Eluting stents
zotarolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_603236
http://www.has-sante.fr/portail/display.jsp?id=c_603238
2007
France
French
ACTIVE CORONARY STENT
coronary artery disease
paclitaxel
Drug-Eluting stents
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_517989
2007
France
French
ACTIVE CORONARY STENT
tubulin modulators
antineoplastic agents, phytogenic
diabetes mellitus
Drug-Eluting stents
coronary stenosis
paclitaxel
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_522790
2007
France
French
ACTIVE CORONARY STENT
diabetes mellitus
sirolimus
Drug-Eluting stents
coronary stenosis
zotarolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_572582
2007
false
France
French
ACTIVE CORONARY STENT
Everolimus
immunosuppressive agents
diabetes mellitus
Drug-Eluting stents
coronary stenosis
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_572610
2007
false
France
French
ACTIVE CORONARY STENT
Everolimus
diabetes mellitus
Drug-Eluting stents
coronary stenosis
immunosuppressive agents
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_455178
2006
France
French
ACTIVE CORONARY STENT
diabetes mellitus
sirolimus
Drug-Eluting stents
coronary stenosis
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_398798
2006
France
French
ACTIVE CORONARY STENT
tubulin modulators
antineoplastic agents, phytogenic
diabetes mellitus
Drug-Eluting stents
coronary stenosis
paclitaxel
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_398739
2006
France
French
ACTIVE CORONARY STENT
diabetes mellitus
sirolimus
Drug-Eluting stents
coronary stenosis
zotarolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_398797
2006
France
French
ACTIVE CORONARY STENT
tubulin modulators
antineoplastic agents, phytogenic
diabetes mellitus
Drug-Eluting stents
coronary stenosis
paclitaxel
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_455185
2006
France
French
ACTIVE CORONARY STENT
diabetes mellitus
sirolimus
Drug-Eluting stents
coronary stenosis
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_455231
2006
France
French
CORONARY STENT, OTHER
carbon
Drug-Eluting stents
coronary stenosis
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_455477
2006
France
French
ACTIVE CORONARY STENT
tubulin modulators
antineoplastic agents, phytogenic
diabetes mellitus
Drug-Eluting stents
coronary stenosis
paclitaxel
health technology assessment
treatment outcome

---
http://kce.fgov.be/fr/publication/report/drug-eluting-stents-en-belgique-health-technology-assessment
2006
Belgium
French
English
CORONARY STENT, OTHER
Drug-Eluting stents
belgium
costs and cost analysis
coronary stenosis
Drug-Eluting stents
economic evaluation
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_398630
2005
France
French
CORONARY STENT, OTHER
prostheses and implants
diabetes mellitus
sirolimus
Drug-Eluting stents
coronary stenosis
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_398722
2005
France
French
ACTIVE CORONARY STENT
tubulin modulators
antineoplastic agents, phytogenic
diabetes mellitus
Drug-Eluting stents
coronary stenosis
paclitaxel
health technology assessment
treatment outcome

---
https://www.cadth.ca/fr/evaluation-economique-des-stents-elution-medicamenteuse-0
https://www.cadth.ca/sites/default/files/pdf/272_drug_eluting_stents_to_f.pdf
2005
true
Canada
French
Drug-Eluting stents
health technology assessment
economic evaluation
drug evaluation

---
http://www.has-sante.fr/portail/display.jsp?id=c_398627
2005
France
French
CORONARY STENT, OTHER
trace elements
silicon
Drug-Eluting stents
coronary stenosis
health technology assessment
treatment outcome

---
https://www.cadth.ca/fr/evaluation-economique-des-inhibiteurs-des-recepteurs-la-glycoproteine-iib-iiia-en-prevision-dune
https://www.cadth.ca/sites/default/files/pdf/203_glycoproteins_tr_f.pdf
2005
true
Canada
French
CORONARY STENT, OTHER
economic evaluation
health technology assessment
arterial occlusive diseases
Drug-Eluting stents
angioplasty, balloon, coronary
drug evaluation
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_398629
2005
France
French
CORONARY STENT, OTHER
prostheses and implants
diabetes mellitus
sirolimus
Drug-Eluting stents
coronary stenosis
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_398584
2004
France
French
CORONARY STENT, OTHER
anti-bacterial agents
antifungal agents
immunosuppressive agents
antibiotics, antineoplastic
diabetes mellitus
sirolimus
Drug-Eluting stents
coronary stenosis
health technology assessment
treatment outcome

---
http://www.cadth.ca/media/pdf/152_No23_absorbablestents_f.pdf
2004
Canada
French
CORONARY STENT, OTHER
Drug-Eluting stents
coronary disease
blood vessel prosthesis
health technology assessment
treatment outcome

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/analyse-economique-des-stents-coronariens-a-elution-medicamenteuse-une-perspective-quebecoise.html
2004
false
Canada
French
CORONARY STENT, OTHER
quebec
Drug-Eluting stents
coronary restenosis
Cost-Benefit analysis
treatment outcome
myocardial revascularization
technology assessment, biomedical
australia
france
united states
spain
myocardial revascularization
coronary restenosis
models, economic
sensitivity and specificity
risk factors
risk
Drug-Eluting stents
patient selection
patient selection
bibliography of medicine
Drug-Eluting stents
economic evaluation
table
figure
health technology assessment

---
http://www.john-libbey-eurotext.fr/fr/revues/medecine/mtc/e-docs/00/04/01/C3/resume.md?type=text.html
http://www.john-libbey-eurotext.fr/fr/revues/medecine/mtc/e-docs/00/04/01/C3/article.md?type=text.html
2004
France
French
journal article
CORONARY STENT, OTHER
Drug-Eluting stents
drug delivery systems
sirolimus
angioplasty, balloon, coronary
coronary stenosis
paclitaxel
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_398556
2004
France
French
CORONARY STENT, OTHER
coronary stenosis
diabetes mellitus
Drug-Eluting stents
coronary stenosis
paclitaxel
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_398474
2003
France
French
CORONARY STENT, OTHER
angioplasty, balloon, coronary
diabetes mellitus
Drug-Eluting stents
coronary stenosis
paclitaxel
health technology assessment
treatment outcome

---
https://www.cadth.ca/sites/default/files/pdf/212_drugelutingstents_cetap_f.pdf
2002
Canada
French
CORONARY STENT, OTHER
blood vessel prosthesis
coronary restenosis
Drug-Eluting stents
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_398455
2002
France
French
CORONARY STENT, OTHER
coronary restenosis
angioplasty, balloon, coronary
diabetes mellitus
sirolimus
Drug-Eluting stents
coronary stenosis
health technology assessment
treatment outcome

---
Nous contacter.
24/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.